SCHEMBL4236506

SCHEMBL4236506

C[C@@H]1C[C@H](Oc2ccc(C(=O)O)cc2)C[C@H](C)N1C

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
LMNA P02545 1/20 0.55
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
SRD5A1 P18405 1/20 0.48
SRD5A2 P31213 1/20 0.47
EPHX2 P34913 7/20 0.45
KMT2A Q03164 1/20 0.45
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
FAAH O00519 1/20 0.42
PARP10 Q53GL7 1/20 0.41
OPRK1 P41145 2/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699096 1.00 ALDH1A1 (0.55) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL4236560 0.83 SLC6A2 (0.67) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL3458790 0.76 SRD5A1 (0.59) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL1977190 0.76 ALDH1A1 (0.70) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL13699366 0.76 ALDH1A1 (0.60) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL23497366 0.75 ALDH1A1 (0.55) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL17869370 0.75 ALDH1A1 (0.55) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL22664149 0.75 ALDH1A1 (0.55) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL17908097 0.75 ALDH1A1 (0.64) ALDH1A1LMNACASP3SENP8SENP6
SCHEMBL4226992 0.74 ALDH1A1 (0.54) ALDH1A1LMNACASP3SENP8SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R ALDH1A1 4542/4885LMNA 2227/4885CASP3 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.